Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Burkitt Lymphoma 22Dendritic Cell Sarcoma, Interdigitating 21Lymphoma, Non-Hodgkin 19Lymphoma, Mantle-Cell 19Lymphoma, B-Cell, Marginal Zone 19Lymphoma, Follicular 18Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 18Sarcoma 17Lymphoma, Large-Cell, Immunoblastic 17Lymphoma, Large B-Cell, Diffuse 17Leukemia, Myeloid, Acute 17Recurrence 16Hodgkin Disease 16Leukemia 15Myelodysplastic Syndromes 14Leukemia, Myeloid, Chronic-Phase 13Leukemia, Myeloid, Accelerated Phase 13Neuroectodermal Tumors, Primitive, Peripheral 11Neuroblastoma 11Multiple Myeloma 11Congenital Abnormalities 11Sarcoma, Ewing 10Myeloproliferative Disorders 10Waldenstrom Macroglobulinemia 9Rhabdomyosarcoma 9Leukemia, Myelomonocytic, Juvenile 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Blast Crisis 9

Interventions

Diathermy 3Surgical Procedures, Operative 1Radiotherapy 1Radiation Dose Hypofractionation 1Melphalan 1Ifosfamide 1Doxorubicin 1Dacarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperthermia × Melphalan × Sarcoma × Clear all
NCT00001577 2008-03-04

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled
DermatologicSarcoma

Hyperthermia, Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡